[an error occurred while processing this directive]
Skip to Main Content

Editor's Page

October 20, 2008
Volume 86, Number 42
p. 5


Nobel Nonsense

NOBODY CRITICIZES the Nobel Prize committees or their selections. The august Swedish academies are just too daunting for criticism. They hand down their verdicts on who is worthy and who is not, and we applaud.

That needs to stop. Some Nobel Prize selections over the past couple of years have been so wrongheaded that it needs to be pointed out.

This year's prize in medicine or physiology is a case in point. Awarding Luc Montagnier and François Barré-Sinoussi half of the prize for discovering HIV—the virus that causes AIDS—while ignoring Robert Gallo's contribution to that discovery is blatant rewriting of scientific history.

I was a young C&EN reporter in San Francisco when the AIDS epidemic broke out in 1981. I started writing about the frightful new disease soon after, even though some members of C&EN's staff thought that the topic was too far afield for a magazine focused on the chemistry enterprise. I was convinced that AIDS was a disease that would become widespread and an important scientific topic in its own right.

Many labs plunged into the desperate search for the cause of AIDS. You have to remember that, in the first few years of the epidemic, AIDS could not be detected until symptoms appeared. Identifying a causative agent would give clinicians tools to diagnose and begin to understand the pathology of the disease.

Five seminal papers associating a human T-cell leukemia virus (HTLV) with AIDS were published in the May 20, 1983, issue of Science. Two were from the lab of Max Essex at Harvard University, two were from Gallo's lab at the National Cancer Institute, and one was from Montagnier's lab at Pasteur Institute in Paris. None of the papers proved the retrovirus caused AIDS, but the association was a strong one. In a "Research News" story in the same issue of Science, Jean Marx quoted Essex as saying, "I definitely do not want anyone to get the impression that we have proof of cause. What we do have is a good lead."

The proof came a year later when Gallo published four consecutive papers in the May 4, 1984, issue of Science. Gallo and his coworkers isolated a retrovirus they called HTLV-III from AIDS patients and patients at risk of developing the disease, began characterizing it, and, most important, grew large quantities of it in the lab. In the July 6, 1984, issue of Science, Montagnier and coworkers reported in two papers that they had isolated a retrovirus they called lymphadenopathy associated virus (LAV) from patients. Later work would show that HTLV-III and LAV were the same virus, which we now call human immunodeficiency virus (HIV).

Sniping about who should get credit for discovering HIV and who should receive patent royalties for an antibody test for the virus began almost immediately and continued for more than a decade. Gallo was charged with and investigated for scientific misconduct in the early 1990s. It was all a bunch of noise. In the early days of the AIDS epidemic the groups were competing and collaborating and samples were being exchanged on a regular basis. Who cares where the virus sample came from? Gallo's team proved it caused AIDS and succeeded in growing it.

This is a fact: In the first decade of the AIDS epidemic, no one in the world did more to advance our understanding of the disease and the virus that causes it than Robert Gallo.

Denying Gallo a Nobel Prize for his work on HIV is reminiscent of last year's slight of Gabor Somorjai. Anyone who knows anything about surface science knows he should have shared the chemistry prize that went to Gerhard Ertl. What Somorjai and Gallo share is that they are both somewhat brash, extremely self-confident Americans, which these days seems to be a major impediment to receiving a Nobel Prize.

The Nobel committees' decisions on these and other recent prizes jeopardize their credibility and raise questions about why we should continue to take the prizes as seriously as we do.

Thanks for reading.

Rudy Baum, Editor-in-chief

Views expressed on this page are those of the author and not necessarily those of ACS.

Save/Share »

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2009 American Chemical Society


Save/Share »



Our log-in process has changed. You need an ACS ID to access member-only content.



Questions or Problems?

Adjust text size:

A- A+

Articles By Topic